期刊文献+

国产荧光免疫分析仪检测降钙素原在急诊科的应用 被引量:2

原文传递
导出
摘要 目的对荧光免疫分析仪定量检测降钙素原进行性能验证,旨在建立一种适用于急诊科的人血清降钙素原定量的及时检测(POCT)系统。方法参照临床实验室标准化委员会(CLSI)相关文件的要求,分别分析其精密度、准确度、最低检测限、线性范围,同时与对照仪器进行相关性比较。结果检测系统各项性能均能满足仪器要求,与对照仪器相关性比较相关系数r2=0.9793。结论该系统既满足临床需求,又保证体积小、方便携带,标本用量少,检测快捷,是一款真正意义上的POCT类降钙素原检测系统,适合急诊科使用。
作者 耿伏生
出处 《医药论坛杂志》 2014年第8期158-159,共2页 Journal of Medical Forum
  • 相关文献

参考文献9

  • 1Meisner M. Pathobiochemistry and clinical use of procalcit on in [ J]. Clin Chim Acta ,2002,323 ( 1-2 ) : 17-29.
  • 2Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis ang infection [ J ]. Lancet, 1993,341 (8844) :515-518.
  • 3Phua J, Koay ES, Lee kit Lactate, proealcitonin, and amino - ter- minal pro - B - type natriuretic peptide versus cytokine measure- ments and clinical severity scores for prognostication in septic shock [ J ]. Shock, 2008,29 ( 3 ) : 328-33.
  • 4王明刚,李春盛,杨军,王硕.降钙素原对危重症患者合并脓毒症早期诊断及预后预测的意义[J].中华全科医师杂志,2007,6(4):215-218. 被引量:26
  • 5CLSI EP15 - A2. User demonstration of performance for precision and accuracy ; Approved gudeline - second Eition ( EP15 - A2 ) [ S ]. Wayne : CLSI,2004.
  • 6CLSI EP17 - A. Protocols for Determination of Limits of Detec- tion and Limits of Quantitation; Approved Guideline ( EP17 - A) [ S]. Wayne:CLSI,2004.
  • 7CLSI EP6 - A. User demonstration of performance for precision and accuracy ; Approved Guideline ( EP6 - A ) [ S ]. Wayne : CLSI,2004.
  • 8Brunkhorst F M, Wegscheider K, Forycki Z F, et al. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sep- sis. and septic shock [ J ]. Intensive Care Med, 2000,26 ( Suppl 2) :S148-152.
  • 9林洪远,盛志勇.全身炎症反应和MODS认识的变化及现状[J].中国危重病急救医学,2001,13(11):643-646. 被引量:117

二级参考文献9

  • 1邱海波,刘大为.《2004严重感染和感染性休克治疗指南》系列讲座(1) 2004严重感染和感染性休克治疗指南概要[J].中国危重病急救医学,2004,16(7):390-393. 被引量:70
  • 2American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med,1992, 20: 864-874.
  • 3Assicot M,Gendrel D,Carsin H,et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet, 1993,341:515-515.
  • 4Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem,2001,38 :483-493.
  • 5Oberhoffer M, Stonans I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med, 1999,134:49-55.
  • 6Nijsten MW, Olinga P,The TH, et al. Procalcltonln behaves as a fast responding aeute phase protein in vivo and in vitro. Crit Care Med,2000,28:458-461.
  • 7Marik PE. Definition of sepsis: not quite time to dump SIRS? Crit Care Med, 2002, 30: 706-708.
  • 8Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med, 1999,17:1019-1025.
  • 9Nylen ES, Whang KT, Snider RH Jr, et al. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med, 1998,26 :1001-1006.

共引文献141

同被引文献11

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部